Active Pharmaceutical Ingredient API News and Research

RSS

VPCI announces successful petition to the FDA for removal from Import Alert

The U.S. Food and Drug Administration (FDA) maintains strict labeling requirements for Active Pharmaceutical Ingredients (APIs). If an API does not maintain adequate labeling as per section 502(f)(1) of the Act, the FDA will consider the material to be misbranded. Foreign APIs which are misbranded are subject to detention without physical examination under FDA's Import Alert 66-66 "Red List."

15 Feb 2012

Teva fourth quarter net revenues increase 28% to $5.7 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.

15 Feb 2012

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan Corporation, plc today reported its fourth quarter and full-year 2011 financial results.

8 Feb 2012

Indoco, DSM sign agreement for commercial cooperation for eight APIs

Royal DSM N.V., today announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012.

31 Jan 2012

Aphios receives NIH's Phase II SBIR grant to develop APH-0703 for AD

Aphios Corporation has received a Phase II SBIR grant from the National Institutes of Health (NIH) amounting to $2.4 million over two years. The National Institute on Aging (NIA), part of the NIH, awarded the grant to the Aphios Corporation to develop an "Alzheimer's Disease Therapeutic."

24 Jan 2012

Almac, MGB Biopharma partner to manufacture MGB-BP3 gram positive antibacterial compound

MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.

17 Jan 2012

Neurotechnology announces new line of embedded biometric technologies

Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.

9 Jan 2012

Magellan launches two fitness products

Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.

7 Jan 2012

Chengdu Tianyin receives approval for renewed High Tech Enterprise status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.

30 Dec 2011

AtheroNova establishes clear development plan for AHRO-001 after positive FDA feedback

AtheroNova Inc., a biotech company focused on the research and development of compounds to regress atherosclerotic plaque has established a clear development plan, including Phase I and Phase II protocol outlines, based on the recently finalized minutes of its pre-IND meeting with the U.S. Food and Drug Administration (FDA) for its AHRO-001, a compound for the treatment of atherosclerosis.

15 Dec 2011

Selcia completes 14C radiolabelled API projects for clients

Selcia has successfully completed 14C radiolabelled API projects on behalf of a diverse range of clients for phase 1 human trials, following MHRA GMP Certification in September 2010. In response to a sharp increase in demand for this specialist service, Selcia has invested to double its capacity for handling GMP radiolabelling projects.

29 Nov 2011

CardioComm demonstrates HeartCheck ECG monitor at Medica 2011

At the world's largest medical trade fair, Medica 2011 held in Düsseldorf last week, CardioComm Solutions, Inc. demonstrated their newly developed remote patient ECG monitoring service, called HeartCheck Smart Monitoring

22 Nov 2011

TPI first quarter revenue decreases 20.5% to $17.5 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter of Fiscal Year 2012.

14 Nov 2011

Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz

Bristol-Myers Squibb Company today announced a technology transfer agreement with the Brazilian Ministry of Health to expand access to Reyataz (atazanavir sulfate) in Brazil.

13 Nov 2011

NeoStem third quarter revenues increase to $17.8 million

NeoStem, Inc., an international biopharmaceutical company with a focus on cell based therapeutics development, today reported third quarter results and recent progress in its business.

11 Nov 2011

AMRI reports $50.2 million total revenue for third quarter 2011

...

9 Nov 2011

TPI announces formulation expansion program for GMOL

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) today announced the formulation expansion program for its flagship product Gingko Mihuan Oral Liquid.

4 Nov 2011

Teva third quarter net sales increase 2% to $4.34 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2011.

2 Nov 2011

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled “Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant”, covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.

11 Oct 2011

TPI revenue increases 48.9% to $95.2 million for fiscal year 2011

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the Fiscal Year 2011.

27 Sep 2011